Allergists and clinical immunologists around the world are increasingly faced with the task of
addressing drug allergy and hypersensitivity due to the increase in drug reactions …

Hypersensitivity reactions to betalactams (BLs) are classified as immediate or
nonimmediate. The former usually appear within 1 h of drug‐intake and are mediated by …

Resolving conflict of interest The Joint Task Force on Practice Parameters (JTFPP) is
committed to ensuring that all guidelines are based on the best scientific evidence at the …

A recent survey of the European Academy of Allergy and Clinical Immunology (EAACI) Drug
Allergy Interest Group (DAIG) on how European allergy specialists deal with beta‐lactam …

Skin tests are of paramount importance for the evaluation of drug hypersensitivity reactions.
Drug skin tests are often not carried out because of lack of concise information on specific …

Drug hypersensitivity reactions (DHR s) are a matter of great concern, both for outpatient
and in hospital care. The evaluation of these patients is complex, because in vivo tests have …

Summary The Standards of Care Committee of the British Society for Allergy and Clinical
Immunology (BSACI) and an expert panel have prepared this guidance for the management …

Allergic reactions to betalactams are the most common cause of adverse drug reactions
mediated by specific immunological mechanisms. Reactions may be induced by all …

These guidelines have been prepared by the Standards of Care Committee (SOCC) of the
British Society for Allergy and Clinical Immunology (BSACI) and are intended for allergists …

To cite this article: Ponvert C, Perrin Y, Bados‐Albiero A, Le Bourgeois M, Karila C,
Delacourt C, Scheinmann P, De Blic J. Allergy to betalactam antibiotics in children: results of …